The long-term trajectory of BioXcel Therapeutics hinges upon the successful clinical advancement and commercialization of its neuroscience pipeline, regulatory approvals for at-home agitation treatments, and disciplined financial capital management. Strategic asset agreements and optimized development paths remain central to sustaining operations and driving future valuation growth.